요로결석증 관리 기기 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 치료 유형별, 최종 용도별, 지역별, 경쟁별(2020-2030년)
Urolithiasis Management Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type, By End Use, By Region, and By Competition, 2020-2030F
상품코드:1881589
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 요로결석증 관리 기기 시장은 2024년에 20억 1,000만 달러로 평가되었으며, 2030년까지 CAGR 4.97%로 성장하여 26억 9,000만 달러에 달할 것으로 예측됩니다.
요로결석증 관리 기기는 신장결석 및 기타 요로결석의 진단, 치료, 예방에 필수적인 다양한 의료기기를 포함합니다. 이 시장의 견조한 성장은 주로 전 세계 요로결석 유병률 증가와 함께 환자의 치료 성과 향상과 회복 기간 단축을 위한 최소침습 수술에 대한 수요 증가에 의해 주도되고 있습니다. 첨단 레이저 쇄석기, 유연성 요관경 등 의료기술의 발전은 보다 효과적인 결석 분쇄 및 제거 솔루션을 제공함으로써 시장 확대를 촉진하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
20억 1,000만 달러
시장 규모 : 2030년
26억 9,000만 달러
CAGR : 2025-2030년
4.97%
가장 빠르게 성장하는 부문
체강내 쇄석술
최대 시장
북미
주요 시장 촉진요인
전 세계 요로결석증 부담의 증가는 주로 요로결석증 관리 기기 시장을 주도하고 있으며, 유병률의 증가로 인해 개입이 필요한 환자 수가 증가하고 있습니다. 생활습관의 변화, 식습관, 대사 장애도 이 환자 수의 증가에 기여하고 있습니다.
주요 시장 과제
고급 요로결석 관리 기기 및 수술적 개입에 따른 높은 비용은 시장 성장의 큰 장벽으로 작용하고 있습니다. 이러한 재정적 부담은 특히 의료 예산이 제한적이고 환자 본인 부담금이 큰 개발도상국에서는 보급을 직접적으로 제한하고 있습니다.
주요 시장 동향
비뇨기과 수술이 외래 수술 센터(ASC)로 전환되고 있는 것은 세계 요로결석 관리 기기 시장에 영향을 미치는 중요한 추세입니다. 이러한 추세는 기존 병원 환경과 비교하여 환자와 의료 시스템에 대한 비용 효율성, 대기 시간 단축, 보다 효율적인 환자 경험 등 ASC가 제공하는 이점에 의해 촉진되고 있습니다.
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 요로결석증 관리 기기 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
치료법별(체외 충격파 쇄석술(ESWL), 체내 쇄석술, 경피적 신장결석 적출술, 기타)
용도별(병원·진료소, 외래 수술 센터, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 요로결석증 관리 기기 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 요로결석증 관리 기기 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 요로결석증 관리 기기 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 요로결석증 관리 기기 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 요로결석증 관리 기기 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 요로결석증 관리 기기 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
Allengers Medical Systems Ltd
Boston Scientific Corp
Cook Medical Inc
CONMED Corp
DiREX Group
Dornier MedTech GmbH
HealthTronics Inc
Karl Storz SE & Co KG
Lumenis Inc
Siemens Healthcare Ltd
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Urolithiasis Management Devices Market, valued at USD 2.01 Billion in 2024, is projected to experience a CAGR of 4.97% to reach USD 2.69 Billion by 2030. Urolithiasis management devices encompass a range of medical instruments essential for the diagnosis, treatment, and prevention of kidney stones and other urinary tract calculi. This market experiences robust growth primarily driven by the increasing global prevalence of urolithiasis, coupled with a growing preference for minimally invasive surgical procedures that offer enhanced patient outcomes and reduced recovery times. Advancements in medical technologies, including sophisticated laser lithotripters and flexible ureteroscopes, further stimulate market expansion by providing more effective stone fragmentation and removal solutions.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 2.01 Billion
Market Size 2030
USD 2.69 Billion
CAGR 2025-2030
4.97%
Fastest Growing Segment
Intracorporeal Lithotripsy
Largest Market
North America
Key Market Drivers
The rising global burden of urolithiasis primarily drives the Global Urolithiasis Management Devices Market, with increasing prevalence expanding the patient population needing intervention. Shifting lifestyles, dietary habits, and metabolic disorders contribute to this growing caseload. According to "The global, regional, and national burden of urolithiasis in 204 countries and territories, 2000-2021: a systematic analysis for the Global Burden of Disease Study 2021" via ResearchGate, in November 2024, there were 106 million incident cases of urolithiasis in 2021. This incidence ensures consistent demand for detection, treatment, and prevention instruments, stimulating market growth. The broader urology devices market reflects robust strategic investment; HealthLeaders Media reported in January 2024 that Boston Scientific acquired Axonics for $3.7 billion, underscoring significant financial commitments.
Key Market Challenges
The high cost associated with advanced urolithiasis management devices and surgical interventions presents a significant impediment to market growth. This financial burden directly restricts widespread adoption, particularly in developing regions where healthcare budgets are limited and patient out-of-pocket expenses are substantial. The investment required for advanced equipment, such as laser lithotripters and flexible ureteroscopes, can be prohibitive for many healthcare facilities. This limitation curtails the market penetration of innovative solutions, thereby reducing potential sales and usage in areas with a high prevalence of urinary tract calculi.
Key Market Trends
The increasing shift of urological procedures to Ambulatory Surgical Centers (ASCs) is a significant trend impacting the global urolithiasis management devices market. This trend is driven by the advantages ASCs offer, such as cost-effectiveness for patients and healthcare systems, shorter waiting times, and a more streamlined patient experience compared to traditional hospital settings. As procedures become less invasive and technological advancements facilitate outpatient care, more complex urological interventions, including certain stone removal procedures, are being safely performed in ASCs. According to a March 2025 report from MedPAC, the volume of ASC surgical procedures per fee-for-service Medicare beneficiary rose by 5.7 percent in 2023. This expansion directly influences device manufacturers to adapt their sales and distribution strategies to cater to the unique procurement and inventory management needs of ASCs, fostering demand for devices optimized for outpatient use.
Key Market Players
Allengers Medical Systems Ltd
Boston Scientific Corp
Cook Medical Inc
CONMED Corp
DiREX Group
Dornier MedTech GmbH
HealthTronics Inc
Karl Storz SE & Co KG
Lumenis Inc
Siemens Healthcare Ltd
Report Scope:
In this report, the Global Urolithiasis Management Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Urolithiasis Management Devices Market, By Treatment Type:
Extracorporeal Shock Wave Lithotripsy (ESWL)
Intracorporeal Lithotripsy
Percutaneous Nephrolithotomy
Others
Urolithiasis Management Devices Market, By End Use:
Hospitals & Clinics
Ambulatory Surgical Centers
Others
Urolithiasis Management Devices Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Urolithiasis Management Devices Market.
Available Customizations:
Global Urolithiasis Management Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Urolithiasis Management Devices Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Treatment Type (Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Others)
5.2.2. By End Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Urolithiasis Management Devices Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Treatment Type
6.2.2. By End Use
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Urolithiasis Management Devices Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Treatment Type
6.3.1.2.2. By End Use
6.3.2. Canada Urolithiasis Management Devices Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Treatment Type
6.3.2.2.2. By End Use
6.3.3. Mexico Urolithiasis Management Devices Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Treatment Type
6.3.3.2.2. By End Use
7. Europe Urolithiasis Management Devices Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Treatment Type
7.2.2. By End Use
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Urolithiasis Management Devices Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Treatment Type
7.3.1.2.2. By End Use
7.3.2. France Urolithiasis Management Devices Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Treatment Type
7.3.2.2.2. By End Use
7.3.3. United Kingdom Urolithiasis Management Devices Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Treatment Type
7.3.3.2.2. By End Use
7.3.4. Italy Urolithiasis Management Devices Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Treatment Type
7.3.4.2.2. By End Use
7.3.5. Spain Urolithiasis Management Devices Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Treatment Type
7.3.5.2.2. By End Use
8. Asia Pacific Urolithiasis Management Devices Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Treatment Type
8.2.2. By End Use
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Urolithiasis Management Devices Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Treatment Type
8.3.1.2.2. By End Use
8.3.2. India Urolithiasis Management Devices Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Treatment Type
8.3.2.2.2. By End Use
8.3.3. Japan Urolithiasis Management Devices Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Treatment Type
8.3.3.2.2. By End Use
8.3.4. South Korea Urolithiasis Management Devices Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Treatment Type
8.3.4.2.2. By End Use
8.3.5. Australia Urolithiasis Management Devices Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Treatment Type
8.3.5.2.2. By End Use
9. Middle East & Africa Urolithiasis Management Devices Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Treatment Type
9.2.2. By End Use
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Urolithiasis Management Devices Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Treatment Type
9.3.1.2.2. By End Use
9.3.2. UAE Urolithiasis Management Devices Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Treatment Type
9.3.2.2.2. By End Use
9.3.3. South Africa Urolithiasis Management Devices Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Treatment Type
9.3.3.2.2. By End Use
10. South America Urolithiasis Management Devices Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Treatment Type
10.2.2. By End Use
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Urolithiasis Management Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Treatment Type
10.3.1.2.2. By End Use
10.3.2. Colombia Urolithiasis Management Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Treatment Type
10.3.2.2.2. By End Use
10.3.3. Argentina Urolithiasis Management Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Treatment Type
10.3.3.2.2. By End Use
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Urolithiasis Management Devices Market: SWOT Analysis
